Skip to the page

Data / Form D filings / Tianzheng Biotechnology Inc

Tianzheng Biotechnology Inc: Form D filing

Tianzheng Biotechnology Inc, a technology company in Denver, CO, filed a Form D with the SEC in 2026. The latest, on July 14, 2026, reports an offering of $5 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1580 N LOGAN ST STE 660 #30327, DENVER CO 80203-1994, Denver, CO, 80202
Phone
1 (303)369-8999
Industry
Other Technology
Entity type
Corporation
Incorporated in
Colorado
Year incorporated
2026
Revenue range
$5,000,001 - $25,000,000
Exemptions claimed
Rule 504
SEC identifier (CIK)
2145260

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 14, 2026New notice$5,000,000$0$5,000,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Cai TiyuanExecutive Officer, Director

Other technology companies in Colorado that filed recently

Every Form D from the week of Jul 13, 2026 · All recent filings in Colorado · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Tianzheng Biotechnology Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.